Ingen CEO Discusses International Expansion Strategy on Money Channel National Talk Radio Show

IGNT.PK is Positioned to Capitalize on the $6 Billion Respiratory Market in Asia, Canada, Europe and Australia


YUCAIPA, Calif., April 13, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), a manufacturer of patented and proprietary respiratory medical devices which helps companies reduce costs and improve home oxygen therapy, will be featured on the world renowned Money Channel's American Scene Radio Wednesday April 14th with Steve Crowley. American Scene Radio attracts over 3 million listeners daily and will feature Scott Sand, who will be discussing the status of IGNT's global sales and distribution. 

After 10 months of preparation and more than $150,000 in fees, the company became ISO Certified effective March 15, 2010 and immediately commenced registration of their ISO Certification with China, Japan, Canada, Europe and Australia. Further, the company has filed for the CE Mark as required in addition to ISO Certification for Europe, Canada and Australia. The registration and CE Mark completion is scheduled for June 2010.

The company's sales have increased approximately 15% so far during its fourth quarter, while we anticipate $11M in revenues by December 31, 2010. Export sales are expected to drive revenues going forward, as the global market continues to display a strong need for our respiratory product line.

"We have had overwhelming shareholder support in favor of our expansion plans to reduce debt and increase product sales. In addition, the required registrations with Asia and Europe will be complete next month, and we can begin moving product to our new global partners. Our increased revenues and cash reserves, in combination with our debt reduction program, enable the company to increase shareholder value," stated Scott R. Sand, Chief Executive Officer and Chairman of the Board.

http://www.ingen-tech.com/

http://www.smartnasalcannula.com/

http://www.ingenpulseoximeter.com/

About Ingen:

Ingen is an ISO Certified medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 billion in the US, and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing US and Foreign Patents and a successful registration with the Food & Drug Administration. The company is establishing domestic and global distribution with manufacture representative organizations, and OEM partners. In 2009, the SMART Nasal Cannula using Oxyview Technology was introduced as the world's first oxygen cannula with an in-line pneumatic oxygen flow meter. In 2010, the company introduced its new INGEN Pulse Oximeter. The Oxyview product line is available to the home care markets, commercial medical markets, aviation, automotive, and government sources. The company is licensed with the Department of Health and Human Services, and manufactures its products in the state of California. With approximately 32 million US patients with Chronic Obstructive Pulmonary Disease (COPD) and 600 million patients worldwide, Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.

The Ingen Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2472

Safe Harbor for Forward-Looking Statements:  This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.



            

Contact Data